Cite
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
MLA
Takigawa, Kosuke, et al. “Volumetric Study Reveals the Relationship between Outcome and Early Radiographic Response during Bevacizumab-Containing Chemoradiotherapy for Unresectable Glioblastoma.” Journal of Neuro-Oncology, vol. 154, no. 2, Sept. 2021, pp. 187–96. EBSCOhost, https://doi.org/10.1007/s11060-021-03812-9.
APA
Takigawa, K., Hata, N., Michiwaki, Y., Hiwatashi, A., Yonezawa, H., Kuga, D., Hatae, R., Sangatsuda, Y., Fujioka, Y., Funakoshi, Y., Otsuji, R., Sako, A., Togao, O., Yoshiura, T., Yoshimoto, K., & Mizoguchi, M. (2021). Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma. Journal of Neuro-Oncology, 154(2), 187–196. https://doi.org/10.1007/s11060-021-03812-9
Chicago
Takigawa, Kosuke, Nobuhiro Hata, Yuhei Michiwaki, Akio Hiwatashi, Hajime Yonezawa, Daisuke Kuga, Ryusuke Hatae, et al. 2021. “Volumetric Study Reveals the Relationship between Outcome and Early Radiographic Response during Bevacizumab-Containing Chemoradiotherapy for Unresectable Glioblastoma.” Journal of Neuro-Oncology 154 (2): 187–96. doi:10.1007/s11060-021-03812-9.